Patent · US Expired

Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions

US6387921B1 · kind B1 · utility

0Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 27, 2001
Grant dateMay 14, 2002
Priority date
Expiry dateNov 27, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D221/26
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines of general formula 1: wherein:R1 and R2, which are identical or different, are each hydrogen, C1-C6-alkyl, C1--C6-alkyloxy, OH, F, Cl, or Br;R3 is hydrogen, F, Cl, Br, methyl, ethyl, OH, or methoxy;R4 and R5, which are identical or different, are each hydrogen, methyl, or ethyl;R6 is hydrogen;X is NH2, NH—(C1-C6-alkyl), N(C1-C6-alkyl)2, the two C1-C6-alkyl groups of which are identical or different, NH—COH, NH—CO(C1-C6-alkyl), or F;A is —(CH2)3—, —CH2—CH2—O—, —CH2—O—CH2—, —(CH2)4—, —CH(C1-C6-alkyl)-O—CH2—, —(CH2)2—O—CH2—, —(CH2)3—O—, —(CH2)5—, —CH2—O—(CH2)3—, —(CH2)2—O—(CH2)2—, —(CH2)3—O—CH2—, —(CH2)4—O—, —CH2—O—CH2—CH2—O—, the racemates thereof, the enantiomers thereof, the diastereomers thereof, and mixtures thereof, and the pharmacologically acceptable acid addition salts thereof, processes for preparing them, and their use as pharmaceu…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.